Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples-Reference-Cited by-同舟云学术

Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples

Published:2016-07-27 Issue:8 Volume:12 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Mastrokolias Anastasios,Pool Rene,Mina Eleni,Hettne Kristina M.,van Duijn Erik,van der Mast Roos C.,van Ommen GertJan,‘t Hoen Peter A. C.,Prehn Cornelia,Adamski Jerzy,van Roon-Mom Willeke

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-016-1084-8.pdf

Reference88 articles.

1. Abildtrup, M., & Shattock, M. (2013). Cardiac Dysautonomia in Huntington’s disease. Journal of Huntington’s disease, 2(3), 251–261.

2. Acuna, A. I., et al. (2013). A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice. Nature Communications, 4, 2917.

3. Adibhatla, R. M., & Hatcher, J. F. (2008). Altered lipid metabolism in brain injury and disorders. Sub-Cellular Biochemistry, 49, 241–268.

4. Adibhatla, R. M., Hatcher, J. F., & Dempsey, R. J. (2006). Lipids and lipidomics in brain injury and diseases. The AAPS Journal, 8(2), E314–E321.

5. Andre, R., Carty, L., & Tabrizi, S. J. (2016). Disruption of immune cell function by mutant huntingtin in Huntington’s disease pathogenesis. Current Opinion in Pharmacology, 26, 33–38.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics and Network-based Approaches in Understanding HD Pathogenesis;Rare Neurodegenerative Disorders - New Insights [Working Title];2024-02-29

2. Discovering life's directed metabolic (sub)paths to interpret human biochemical markers using the DSMN tool;Digital Discovery;2024

3. Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases;Altered Metabolism: A Major Contributor of Comorbidities in Neurodegenerative Diseases;2024

4. Metabolomics: An Emerging “Omics” Platform for Systems Biology and Its Implications for Huntington Disease Research;Metabolites;2023-12-18

5. Astragalus polysaccharide ameliorated complex factor-induced chronic fatigue syndrome by modulating the gut microbiota and metabolites in mice;Biomedicine & Pharmacotherapy;2023-07